p38 MAP kinase inhibitor

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for p38 MAP kinase inhibitor, covering 2015-12-07 to 2015-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis [Phase 2]